(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are NX FILTRATION, ULTIMOVACS, and PETROLIA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NX FILTRATION (NXFIL.AS) | 6.19 | 16.79% | 2024-05-29 12:03:08 |
| ULTIMOVACS (ULTI.OL) | 9.18 | 13.75% | 2024-05-29 12:44:06 |
| PETROLIA (PSE.OL) | 5.30 | 6.85% | 2024-05-29 12:42:12 |
| FOUNTAIN (FOU.BR) | 1.29 | 6.61% | 2024-05-29 12:06:09 |
| HØLAND OG SETSKOG (HSPG.OL) | 128.98 | 5.7% | 2024-05-29 12:40:34 |
| EQVA (EQVA.OL) | 5.24 | 5.07% | 2024-05-29 12:25:58 |
| TEKNA HOLDING (TEKNA.OL) | 5.18 | 4.65% | 2024-05-29 12:43:53 |
| SCHIBSTED SER. A (SCHA.OL) | 371.00 | 4.51% | 2024-05-29 12:42:57 |
| CADELER (CADLR.OL) | 64.70 | 4.19% | 2024-05-29 12:25:22 |
| AFFLUENT MEDICAL (AFME.PA) | 1.75 | 3.86% | 2024-05-29 12:45:12 |
The three biggest losers today are PCI BIOTECH HOLD, VIVORYON, and NORTHERN OCEAN LTD.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| PCI BIOTECH HOLD (PCIB.OL) | 2.17 | -22.97% | 2024-05-29 12:42:09 |
| VIVORYON (VVY.AS) | 2.57 | -10.84% | 2024-05-29 12:04:26 |
| NORTHERN OCEAN LTD (NOL.OL) | 9.18 | -9.47% | 2024-05-29 12:41:39 |
| POLIGHT (PLT.OL) | 2.53 | -9.32% | 2024-05-29 12:42:23 |
| REINET INVESTMENTS (REINA.AS) | 23.00 | -8% | 2024-05-29 12:03:40 |
| OCEANTEAM (OTS.OL) | 1.14 | -7.69% | 2024-05-29 12:41:47 |
| NEL (NEL.OL) | 7.93 | -6.66% | 2024-05-29 12:41:22 |
| SEQUANA MEDICAL (SEQUA.BR) | 1.62 | -6.63% | 2024-05-29 12:21:20 |
| FUT.CLUBE PORTO (FCP.LS) | 1.33 | -6.34% | 2024-05-29 12:23:10 |
| EBUSCO HOLDING (EBUS.AS) | 2.71 | -5.9% | 2024-05-29 12:01:40 |
Winners today
1. NX FILTRATION (NXFIL.AS)
16.79% Price Change
NX Filtration N.V. develops, manufactures, and sells hollow fiber membrane modules in Netherlands, Europe, North America, Asia, and internationally. The company offers direct nanofiltration, ultrafiltration, and microfiltration membrane modules that remove bacteria, viruses, micropollutants, color, and selective salts from water without pre-treatment and use of chemicals. It provides HYDRAcap ultrafiltration modules to treat surface water, ground water, sedawater, and wastewaters as pretreatment to reverse osmosis and nanofiltration; and Projection Tool, and intuitive and online platform that enables the rapid and iterative system design for dNF membranes. In addition, the company offers integrated rack design and testing and piloting services. The company was incorporated in 2016 and is headquartered in Enschede, the Netherlands.
AEX-Index ended the session with NX FILTRATION jumping 16.79% to €6.19 on Wednesday while AEX-Index fell 0.7% to €905.83.
Earnings Per Share
As for profitability, NX FILTRATION has a trailing twelve months EPS of €-0.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.78%.
More news about NX FILTRATION.
2. ULTIMOVACS (ULTI.OL)
13.75% Price Change
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS jumping 13.75% to €9.18 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.71% to €1,423.64, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.94%.
Moving Average
ULTIMOVACS’s value is way under its 50-day moving average of kr33.11 and way below its 200-day moving average of kr88.30.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ULTIMOVACS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for ULTIMOVACS is 1187410 which is 32.07% below its average volume of 1748050.
Yearly Top and Bottom Value
ULTIMOVACS’s stock is valued at kr9.18 at 22:40 EST, way under its 52-week high of kr178.60 and way above its 52-week low of kr6.07.
More news about ULTIMOVACS.
3. PETROLIA (PSE.OL)
6.85% Price Change
Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.
Oslo Børs Benchmark Index_GI ended the session with PETROLIA rising 6.85% to €5.30 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.71% to €1,423.64, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, PETROLIA has a trailing twelve months EPS of kr0.32.
PE Ratio
PETROLIA has a trailing twelve months price to earnings ratio of 16.56. Meaning, the purchaser of the share is investing kr16.56 for every norwegian krone of annual earnings.
More news about PETROLIA.
4. FOUNTAIN (FOU.BR)
6.61% Price Change
Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in in France, Belgium, the Netherlands, and rest of European Countries. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was incorporated in 1972 and is based in Braine l'Alleud, Belgium.
BEL 20 ended the session with FOUNTAIN jumping 6.61% to €1.29 on Wednesday while BEL 20 slid 0.65% to €3,922.53.
Earnings Per Share
As for profitability, FOUNTAIN has a trailing twelve months EPS of €0.18.
PE Ratio
FOUNTAIN has a trailing twelve months price to earnings ratio of 7.17. Meaning, the purchaser of the share is investing €7.17 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FOUNTAIN’s stock is considered to be oversold (<=20).
Volatility
FOUNTAIN’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.83%, a negative 1.06%, and a positive 3.83%.
FOUNTAIN’s highest amplitude of average volatility was 0.83% (last week), 2.55% (last month), and 3.83% (last quarter).
More news about FOUNTAIN.
5. HØLAND OG SETSKOG (HSPG.OL)
5.7% Price Change
Høland og Setskog Sparebank provides banking services for the personal and corporate markets in Norway. It offers savings and pension accounts; consumer loans, business loans, mortgage loans, car loans, and loans for motorbikes, ATVs, motorhomes, caravans, snowmobiles, and boats; and refinancing, credit cards, mobile and online banking, bank guarantee, overdrafts, leasing, and factoring and invoice sales, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. Høland og Setskog Sparebank was founded in 1849 and is headquartered in Bjørkelangen, Norway.
Oslo Børs Benchmark Index_GI ended the session with HØLAND OG SETSKOG rising 5.7% to €128.98 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.71% to €1,423.64.
Earnings Per Share
As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr10.75.
PE Ratio
HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 12. Meaning, the purchaser of the share is investing kr12 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.83%.
Moving Average
HØLAND OG SETSKOG’s value is above its 50-day moving average of kr125.74 and higher than its 200-day moving average of kr128.49.
Sales Growth
HØLAND OG SETSKOG’s sales growth is negative 17.5% for the present quarter and negative 7% for the next.
Volume
Today’s last reported volume for HØLAND OG SETSKOG is 186 which is 70.64% above its average volume of 109.
More news about HØLAND OG SETSKOG.
6. EQVA (EQVA.OL)
5.07% Price Change
Eqva ASA, provides technical solutions and services to maritime and land based industries in Norway and internationally. It operates in three segments: Products, Solutions & Renewables; Real Estate; and Other. The company provides technical installations to the land-based and maritime industry; and develops and operates small-scale hydropower plants. It also engages in real estate business. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was incorporated in 1999 and is headquartered in Kvinnherad, Norway.
Oslo Børs Benchmark Index_GI ended the session with EQVA rising 5.07% to €5.24 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.71% to €1,423.64, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, EQVA has a trailing twelve months EPS of kr0.23.
PE Ratio
EQVA has a trailing twelve months price to earnings ratio of 22.78. Meaning, the purchaser of the share is investing kr22.78 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.
Volume
Today’s last reported volume for EQVA is 98558 which is 114.08% above its average volume of 46037.
Yearly Top and Bottom Value
EQVA’s stock is valued at kr5.24 at 22:40 EST, way above its 52-week high of kr4.00.
More news about EQVA.
7. TEKNA HOLDING (TEKNA.OL)
4.65% Price Change
Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.
Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING rising 4.65% to €5.18 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.71% to €1,423.64.
Earnings Per Share
As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.01.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.75%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 77.1%, now sitting on 41.88M for the twelve trailing months.
Yearly Top and Bottom Value
TEKNA HOLDING’s stock is valued at kr5.18 at 22:40 EST, below its 52-week low of kr5.30.
More news about TEKNA HOLDING.
8. SCHIBSTED SER. A (SCHA.OL)
4.51% Price Change
Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, Delivery and Growth & Investments segments. It operates online classifieds that provide technology-based services to connect buyers and sellers, and facilitate transactions, including job offers, real estate, cars, travel, consumer goods, and others. The company also publishes newspapers under the VG, Aftenposten, E24, Bergens Tidende, Stavanger Aftenblad, Aftonbladet, Svenska Dagbladet, and Omni brands in paper and digital format; and operates Podme, a podcast platform. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. A rising 4.51% to €371.00 on Wednesday, after four sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.71% to €1,423.64, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, SCHIBSTED SER. A has a trailing twelve months EPS of kr73.45.
PE Ratio
SCHIBSTED SER. A has a trailing twelve months price to earnings ratio of 5.05. Meaning, the purchaser of the share is investing kr5.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.07%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 133.1% and 25.6%, respectively.
More news about SCHIBSTED SER. A.
9. CADELER (CADLR.OL)
4.19% Price Change
Cadeler A/S operates as an offshore wind farm transportation and installation contractor in Denmark. It also provides wind farm construction, maintenance, decommissioning, and other tasks within the offshore industry, as well as marine and engineering services. The company owns and operates four offshore jack-up windfarm installation vessels. Cadeler A/S was incorporated in 2008 and is headquartered in Copenhagen, Denmark.
Oslo Børs Benchmark Index_GI ended the session with CADELER rising 4.19% to €64.70 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.71% to €1,423.64, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, CADELER has a trailing twelve months EPS of kr0.7.
PE Ratio
CADELER has a trailing twelve months price to earnings ratio of 92.43. Meaning, the purchaser of the share is investing kr92.43 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Yearly Top and Bottom Value
CADELER’s stock is valued at kr64.70 at 22:40 EST, way above its 52-week high of kr51.00.
Volume
Today’s last reported volume for CADELER is 293863 which is 46.12% below its average volume of 545470.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CADELER’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 121.3%, now sitting on 106.42M for the twelve trailing months.
More news about CADELER.
10. AFFLUENT MEDICAL (AFME.PA)
3.86% Price Change
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
CAC 40 ended the session with AFFLUENT MEDICAL jumping 3.86% to €1.75 on Wednesday while CAC 40 dropped 1.52% to €7,935.03.
Earnings Per Share
As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.
More news about AFFLUENT MEDICAL.
Losers Today
1. PCI BIOTECH HOLD (PCIB.OL)
-22.97% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 22.97% to €2.17 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.71% to €1,423.64.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.
Volatility
PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was 20.36%, 4.88%, and 4.50%.
PCI BIOTECH HOLD’s highest amplitude of average volatility was 21.21% (last week), 7.98% (last month), and 4.50% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCI BIOTECH HOLD’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for PCI BIOTECH HOLD is 6886150 which is 3056.55% above its average volume of 218154.
More news about PCI BIOTECH HOLD.
2. VIVORYON (VVY.AS)
-10.84% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON falling 10.84% to €2.57 on Wednesday while AEX-Index dropped 0.7% to €905.83.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.
More news about VIVORYON.
3. NORTHERN OCEAN LTD (NOL.OL)
-9.47% Price Change
Northern Ocean Ltd., a drilling contractor, provides offshore contract drilling services for the oil and gas industry worldwide. The company owns two semi-submersible rigs. It also invests in battery systems and power generation solutions. Northern Ocean Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN OCEAN LTD falling 9.47% to €9.18 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.71% to €1,423.64.
Earnings Per Share
As for profitability, NORTHERN OCEAN LTD has a trailing twelve months EPS of kr-4.13.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.03%.
Yearly Top and Bottom Value
NORTHERN OCEAN LTD’s stock is valued at kr9.18 at 22:40 EST, way below its 52-week high of kr15.88 and way above its 52-week low of kr7.50.
More news about NORTHERN OCEAN LTD.
4. POLIGHT (PLT.OL)
-9.32% Price Change
poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLIGHT sliding 9.32% to €2.53 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.71% to €1,423.64.
Earnings Per Share
As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.
Yearly Top and Bottom Value
POLIGHT’s stock is valued at kr2.53 at 22:40 EST, way below its 52-week high of kr25.70 and higher than its 52-week low of kr2.34.
More news about POLIGHT.
5. REINET INVESTMENTS (REINA.AS)
-8% Price Change
Reinet Investments S.C.A. operates as a securitization vehicle in Luxembourg. The company, through its subsidiary, Reinet Fund S.C.A., F.I.S., invests in assets. Reinet Investments Manager S.A. operates as a general partner of Reinet Investments S.C.A. The company was formerly known as Richemont S.A. and changed its name to Reinet Investments S.C.A. in October 2008. Reinet Investments S.C.A. was incorporated in 1979 and is based in Luxembourg City, Luxembourg.
AEX-Index ended the session with REINET INVESTMENTS sliding 8% to €23.00 on Wednesday, following the last session’s upward trend. AEX-Index dropped 0.7% to €905.83, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, REINET INVESTMENTS has a trailing twelve months EPS of €1.25.
PE Ratio
REINET INVESTMENTS has a trailing twelve months price to earnings ratio of 18.4. Meaning, the purchaser of the share is investing €18.4 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.16%.
More news about REINET INVESTMENTS.
6. OCEANTEAM (OTS.OL)
-7.69% Price Change
Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.
Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM dropping 7.69% to €1.14 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.71% to €1,423.64.
Earnings Per Share
As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.
Moving Average
OCEANTEAM’s value is below its 50-day moving average of kr1.17 and way below its 200-day moving average of kr1.40.
Yearly Top and Bottom Value
OCEANTEAM’s stock is valued at kr1.14 at 22:40 EST, way under its 52-week high of kr2.01 and way above its 52-week low of kr0.92.
More news about OCEANTEAM.
7. NEL (NEL.OL)
-6.66% Price Change
Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEL dropping 6.66% to €7.93 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.71% to €1,423.64.
Earnings Per Share
As for profitability, NEL has a trailing twelve months EPS of kr-0.47.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.
More news about NEL.
8. SEQUANA MEDICAL (SEQUA.BR)
-6.63% Price Change
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
BEL 20 ended the session with SEQUANA MEDICAL dropping 6.63% to €1.62 on Wednesday while BEL 20 slid 0.65% to €3,922.53.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.
More news about SEQUANA MEDICAL.
9. FUT.CLUBE PORTO (FCP.LS)
-6.34% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO sliding 6.34% to €1.33 on Wednesday, after two successive sessions in a row of losses. PSI dropped 1.62% to €6,798.09, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.
Volume
Today’s last reported volume for FUT.CLUBE PORTO is 1234 which is 191.72% above its average volume of 423.
Moving Average
FUT.CLUBE PORTO’s worth is way above its 50-day moving average of €1.19 and way higher than its 200-day moving average of €1.16.
Yearly Top and Bottom Value
FUT.CLUBE PORTO’s stock is valued at €1.33 at 22:40 EST, higher than its 52-week high of €1.30.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 155.82M for the twelve trailing months.
More news about FUT.CLUBE PORTO.
10. EBUSCO HOLDING (EBUS.AS)
-5.9% Price Change
Ebusco Holding N.V., together with its subsidiaries, engages in the development, manufacture, and distribution of zero emission buses and charging systems. It also provides ancillary products and services to electric vehicle ecosystem; and manufactures and supplies energy storage systems and mobile energy containers, as well as repair and maintenance services. The company operates in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.
AEX-Index ended the session with EBUSCO HOLDING falling 5.9% to €2.71 on Wednesday, after three consecutive sessions in a row of gains. AEX-Index fell 0.7% to €905.83, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-2.01.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.19%.
Volatility
EBUSCO HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.35%, a negative 0.19%, and a positive 3.60%.
EBUSCO HOLDING’s highest amplitude of average volatility was 1.95% (last week), 2.34% (last month), and 3.60% (last quarter).
More news about EBUSCO HOLDING.
Stay up to date with our winners and losers daily report
